Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Menglei Jia

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
ACS Nano|February 6, 2023
(2×1) Reconstruction Mechanism of Rutile TiO<sub>2</sub>(011) SurfaceMenglei Jia, Jianfu Chen, Haifeng Wang
Journal of Computational Chemistry|December 14, 2020
CATKINAS: A large-scale catalytic microkinetic analysis software for mechanism auto-analysis and catalyst screeningJianfu Chen, Menglei Jia, Peijun Hu, et al.
Journal of Pharmaceutical Sciences|May 20, 2024
Nanoliposomes Encapsulated Rapamycin/Resveratrol to Induce Apoptosis and Ferroptosis for Enhanced Colorectal Cancer TherapyMenglei Jia, Xiaoxiao Tan, Zhongwen Yuan, et al.
The Journal of Chemical Physics|January 15, 2021
SSIA: A sensitivity-supervised interlock algorithm for high-performance microkinetic solvingJianfu Chen, Menglei Jia, Zhuangzhuang Lai, et al.
The Journal of Pharmacy and Pharmacology|July 27, 2023
Synergistic anti-tumour activity of ginsenoside Rg3 and doxorubicin on proliferation, metastasis and angiogenesis in osteosarcoma by modulating mTOR/HIF-1α/VEGF and EMT signalling pathwaysXiangfeng Zeng, Shengyao Liu, Hua Yang, et al.
International Journal of Pharmaceutics|August 16, 2023
Multi-targeting liposomal codelivery of cisplatin and rapamycin inhibits pancreatic cancer growth and metastasis through stromal modulationWenting Zhu, Hang Yu, Menglei Jia, et al.
Biomaterials Science|November 3, 2023
Stromal and tumor immune microenvironment reprogramming through multifunctional cisplatin-based liposomes boosts the efficacy of anti-PD-1 immunotherapy in pancreatic cancerHang Yu, Wenting Zhu, Caiyan Lin, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 14, 2024
Rapamycin circumvents anti PD-1 therapy resistance in colorectal cancer by reducing PD-L1 expression and optimizing the tumor microenvironmentMenglei Jia, Zhongwen Yuan, Hang Yu, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
ACS Nano|February 6, 2023
(2×1) Reconstruction Mechanism of Rutile TiO<sub>2</sub>(011) SurfaceMenglei Jia, Jianfu Chen, Haifeng Wang
Journal of Computational Chemistry|December 14, 2020
CATKINAS: A large-scale catalytic microkinetic analysis software for mechanism auto-analysis and catalyst screeningJianfu Chen, Menglei Jia, Peijun Hu, et al.
Journal of Pharmaceutical Sciences|May 20, 2024
Nanoliposomes Encapsulated Rapamycin/Resveratrol to Induce Apoptosis and Ferroptosis for Enhanced Colorectal Cancer TherapyMenglei Jia, Xiaoxiao Tan, Zhongwen Yuan, et al.
The Journal of Chemical Physics|January 15, 2021
SSIA: A sensitivity-supervised interlock algorithm for high-performance microkinetic solvingJianfu Chen, Menglei Jia, Zhuangzhuang Lai, et al.
The Journal of Pharmacy and Pharmacology|July 27, 2023
Synergistic anti-tumour activity of ginsenoside Rg3 and doxorubicin on proliferation, metastasis and angiogenesis in osteosarcoma by modulating mTOR/HIF-1α/VEGF and EMT signalling pathwaysXiangfeng Zeng, Shengyao Liu, Hua Yang, et al.
International Journal of Pharmaceutics|August 16, 2023
Multi-targeting liposomal codelivery of cisplatin and rapamycin inhibits pancreatic cancer growth and metastasis through stromal modulationWenting Zhu, Hang Yu, Menglei Jia, et al.
Biomaterials Science|November 3, 2023
Stromal and tumor immune microenvironment reprogramming through multifunctional cisplatin-based liposomes boosts the efficacy of anti-PD-1 immunotherapy in pancreatic cancerHang Yu, Wenting Zhu, Caiyan Lin, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 14, 2024
Rapamycin circumvents anti PD-1 therapy resistance in colorectal cancer by reducing PD-L1 expression and optimizing the tumor microenvironmentMenglei Jia, Zhongwen Yuan, Hang Yu, et al.
Pageof 1